Skogestad J, Albert I, Hougen K, Lothe GB, Lunde M, Søvik Eken O, Veras I, Thi-Huynh NT, Børstad M, Marshall S, Shen X, Louch WE, Louise Robinson E, Cleveland JC, Ambardekar AV, Schwisow JA, Jonas E, Calejo AIC, Morth JP, Taskén K, Melleby AO, Lunde PK, Sjaastad I, Carlson CR, Aronsen JM (2023)
Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure
Circulation (in press)
DOI 10.1161/CIRCULATIONAHA.121.054168, PubMed 36876489

Giliberto M, Santana LM, Holien T, Misund K, Nakken S, Vodak D, Hovig E, Meza-Zepeda LA, Coward E, Waage A, Taskén K, Skånland SS (2022)
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
Front Oncol, 12, 1040730
DOI 10.3389/fonc.2022.1040730, PubMed 36523963

Wei Q, Taskén K (2022)
Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development
Biochem J, 479 (20), 2219-2260
DOI 10.1042/BCJ20210233, PubMed 36305711